{"id":"https://openalex.org/W2787665771","doi":"https://doi.org/10.1021/acs.bioconjchem.7b00774","title":"SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy","display_name":"SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy","publication_year":2018,"publication_date":"2018-02-07","ids":{"openalex":"https://openalex.org/W2787665771","doi":"https://doi.org/10.1021/acs.bioconjchem.7b00774","mag":"2787665771","pmid":"https://pubmed.ncbi.nlm.nih.gov/29412642","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7278042"},"language":"en","primary_location":{"id":"doi:10.1021/acs.bioconjchem.7b00774","doi":"https://doi.org/10.1021/acs.bioconjchem.7b00774","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.bioconjchem.7b00774","pdf_url":null,"source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7278042","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089263486","display_name":"Jordan A. Naumann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jordan A. Naumann","raw_affiliation_strings":["University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States","Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota 55455, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I4390039358"]},{"raw_affiliation_string":"Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016244640","display_name":"John C. Widen","orcid":"https://orcid.org/0000-0002-8973-1509","observed_orcids":["https://orcid.org/0000-0002-8973-1509"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Widen","raw_affiliation_strings":["Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089769841","display_name":"Leslie A. Jonart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leslie A. Jonart","raw_affiliation_strings":["University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States","Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota 55455, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I4390039358"]},{"raw_affiliation_string":"Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103195868","display_name":"Maryam Ebadi","orcid":"https://orcid.org/0009-0004-5848-4789","observed_orcids":["https://orcid.org/0009-0004-5848-4789","https://orcid.org/0000-0001-9452-1488"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maryam Ebadi","raw_affiliation_strings":["University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States","Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota 55455, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I4390039358"]},{"raw_affiliation_string":"Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109393347","display_name":"Jian Hua Tang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jian Tang","raw_affiliation_strings":["Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048993280","display_name":"David J. Gordon","orcid":"https://orcid.org/0000-0003-1830-4371","observed_orcids":["https://orcid.org/0000-0003-1830-4371"]},"institutions":[{"id":"https://openalex.org/I126307644","display_name":"University of Iowa","ror":"https://ror.org/036jqmy94","country_code":"US","type":"education","lineage":["https://openalex.org/I126307644"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Gordon","raw_affiliation_strings":["Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, Iowa 52242, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Iowa, Iowa City, Iowa 52242, United States","institution_ids":["https://openalex.org/I126307644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009655060","display_name":"Daniel A. Harki","orcid":"https://orcid.org/0000-0001-5950-931X","observed_orcids":["https://orcid.org/0000-0001-5950-931X"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Harki","raw_affiliation_strings":["Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States"],"raw_orcid":"https://orcid.org/0000-0001-5950-931X","affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I130238516"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000082261","display_name":"Peter M. Gordon","orcid":"https://orcid.org/0000-0002-3159-1881","observed_orcids":["https://orcid.org/0000-0002-3159-1881"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Peter M. Gordon","raw_affiliation_strings":["University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States","Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota 55455, United States"],"raw_orcid":"https://orcid.org/0000-0002-3159-1881","affiliations":[{"raw_affiliation_string":"University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I4390039358"]},{"raw_affiliation_string":"Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Minnesota, Minneapolis, Minnesota 55455, United States","institution_ids":["https://openalex.org/I130238516"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5000082261"],"corresponding_institution_ids":["https://openalex.org/I130238516","https://openalex.org/I4390039358"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.6471,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.54966378,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"29","issue":"4","first_page":"1111","last_page":"1118"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8877000212669373,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.8877000212669373,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.05550000071525574,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10131","display_name":"Gold and Silver Nanoparticles Synthesis and Applications","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2504","display_name":"Electronic, Optical and Magnetic Materials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.9789999723434448},{"id":"https://openalex.org/keywords/gold-nanoparticles","display_name":"gold nanoparticles","score":0.9829999804496765},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.8370000123977661},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.9589999914169312},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.7329999804496765},{"id":"https://openalex.org/keywords/chemotherapeutic-drug-delivery","display_name":"chemotherapy delivery","score":0.42800000309944153}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.8332788944244385},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8000257611274719},{"id":"https://openalex.org/C104819515","wikidata":"https://www.wikidata.org/wiki/Q900961","display_name":"Colloidal gold","level":3,"score":0.6360259652137756},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5977344512939453},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5912614464759827},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.525988757610321},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5024101734161377},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4918820858001709},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.46039053797721863},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.44158294796943665},{"id":"https://openalex.org/C24107716","wikidata":"https://www.wikidata.org/wiki/Q123619","display_name":"Nucleic acid","level":2,"score":0.44085195660591125},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4122801125049591},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40415212512016296},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.2828161418437958},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.2501857578754425},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24154844880104065},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09262001514434814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09101438522338867},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08661958575248718},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.08633214235305786},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0745423436164856},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006046","descriptor_name":"Gold","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012512","descriptor_name":"Sarcoma, Ewing","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053768","descriptor_name":"Metal Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.bioconjchem.7b00774","doi":"https://doi.org/10.1021/acs.bioconjchem.7b00774","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.bioconjchem.7b00774","pdf_url":null,"source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},{"id":"pmid:29412642","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29412642","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7278042","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7278042","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Bioconjug Chem","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7278042","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7278042","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Bioconjug Chem","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2170937311","display_name":"Gene Expression Signature Based Screening in Ewing Sarcoma","funder_award_id":"R37CA217910","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000868713","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA086862","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000895342","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA077598","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306156","display_name":"Children's Cancer Research Fund","ror":"https://ror.org/02wv5fj21"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W178543369","https://openalex.org/W1536103762","https://openalex.org/W1824189202","https://openalex.org/W1874784862","https://openalex.org/W1964815032","https://openalex.org/W1975410130","https://openalex.org/W1994051304","https://openalex.org/W1995742898","https://openalex.org/W2008160002","https://openalex.org/W2010078128","https://openalex.org/W2029758127","https://openalex.org/W2038465110","https://openalex.org/W2044351445","https://openalex.org/W2049628338","https://openalex.org/W2050620942","https://openalex.org/W2053622985","https://openalex.org/W2092938559","https://openalex.org/W2101959302","https://openalex.org/W2103336131","https://openalex.org/W2107989095","https://openalex.org/W2112772060","https://openalex.org/W2119214388","https://openalex.org/W2121322725","https://openalex.org/W2124330382","https://openalex.org/W2127206245","https://openalex.org/W2129191745","https://openalex.org/W2137158680","https://openalex.org/W2138153808","https://openalex.org/W2149228256","https://openalex.org/W2157976581","https://openalex.org/W2164559547","https://openalex.org/W2181227864","https://openalex.org/W2274657786","https://openalex.org/W2409722041","https://openalex.org/W2515693035","https://openalex.org/W2525696025"],"related_works":["https://openalex.org/W2409722041","https://openalex.org/W2053622985","https://openalex.org/W2067336587","https://openalex.org/W4225001011","https://openalex.org/W2050620942","https://openalex.org/W2079287443","https://openalex.org/W4312442933","https://openalex.org/W3114052667","https://openalex.org/W2947975085","https://openalex.org/W4409331143"],"abstract_inverted_index":{"The":[0,63],"limited":[1],"delivery":[2,28,114],"of":[3,13,55,65,82,118],"chemotherapy":[4],"agents":[5,15],"to":[6,59,70,102,150,156],"cancer":[7,50,61,84,144],"cells":[8,126],"and":[9,29,79,115,132,146],"the":[10,53,60,71,77,80,83,98,112],"nonspecific":[11],"action":[12],"these":[14],"are":[16],"significant":[17],"challenges":[18],"in":[19,32,88,123,130,133],"oncology.":[20],"We":[21,91],"have":[22,92],"previously":[23],"developed":[24,94],"a":[25,34,42,49,89],"customizable":[26],"drug":[27,43,66],"activation":[30],"system":[31],"which":[33],"nucleic":[35],"acid":[36],"functionalized":[37],"gold":[38,121],"nanoparticle":[39],"(Au-NP)":[40],"delivers":[41],"that":[44,153],"is":[45,73],"selectively":[46],"activated":[47],"within":[48],"cell":[51,85],"by":[52,75],"presence":[54,78],"an":[56],"mRNA":[57,87],"unique":[58],"cell.":[62,90],"amount":[64],"released":[67],"from":[68,120],"sequestration":[69],"Au-NP":[72],"determined":[74],"both":[76,111],"abundance":[81],"specific":[86],"now":[93],"this":[95,142],"technology":[96],"for":[97,141],"potent,":[99],"but":[100],"difficult":[101],"deliver,":[103],"topoisomerase":[104,157],"I":[105,158],"inhibitor":[106],"SN-38.":[107],"Herein,":[108],"we":[109],"demonstrate":[110],"efficient":[113],"selective":[116],"release":[117],"SN-38":[119],"nanoparticles":[122],"Ewing":[124],"sarcoma":[125],"with":[127],"resulting":[128],"efficacy":[129],"vitro":[131],"vivo.":[134],"These":[135],"results":[136],"provide":[137],"further":[138],"preclinical":[139],"validation":[140],"novel":[143],"therapy":[145],"may":[147],"be":[148],"extendable":[149],"other":[151],"cancers":[152],"exhibit":[154],"sensitivity":[155],"inhibitors.":[159]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-02-23T00:00:00"}